Filing Details

Accession Number:
0001127430-16-000155
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-11-09 16:31:15
Reporting Period:
2016-11-07
Filing Date:
2016-11-09
Accepted Time:
2016-11-09 16:31:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1104506 Insmed Inc INSM Pharmaceutical Preparations (2834) 541972729
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1401017 Nicole S Orlov Schaeffer 10 Finderne Avenue
Building 10
Bridgewater NJ 08807
Svp, Hr & Corp. Svcs. No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-11-07 37,500 $6.96 37,500 No 4 M Direct
Common Stock Disposition 2016-11-07 37,500 $11.78 0 No 4 S Direct
Common Stock Acquisiton 2016-11-07 23,265 $6.96 23,265 No 4 M Direct
Common Stock Disposition 2016-11-07 23,265 $11.78 0 No 4 S Direct
Common Stock Acquisiton 2016-11-09 8,009 $6.96 8,009 No 4 M Direct
Common Stock Disposition 2016-11-09 8,009 $13.25 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Disposition 2016-11-07 37,500 $0.00 37,500 $6.96
Common Stock Stock Option Disposition 2016-11-07 23,265 $0.00 23,265 $6.96
Common Stock Stock Option Disposition 2016-11-09 8,009 $0.00 8,009 $6.96
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
16,226 2023-01-02 No 4 M Direct
8,009 2023-01-02 No 4 M Direct
0 2023-01-02 No 4 M Direct
Footnotes
  1. The price in column 4 is a weighted average price. The prices in these transactions range from $11.75 to $11.91.
  2. Stock options granted under the Company's 2000 Stock Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.